{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:30Z","timestamp":1786118850150,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10350-007-9038-x","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T13:31:25Z","timestamp":1193319085000},"page":"2188-2193","source":"Crossref","is-referenced-by-count":16,"title":["Fecal Calprotectin as a Predictor of Abnormal Colonic Histology"],"prefix":"10.1097","volume":"50","author":[{"given":"Ariella Bar-Gil","family":"Shitrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Stankiewics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shitrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Peled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalman","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"9038_CR1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/gut.2004.039032","volume":"53","author":"G Hoff","year":"2004","unstructured":"Hoff G, Grotmol T, Thilis-Evensen E, et al. Testing for fecal calprotectin in the Norwegian colorectal cancer prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood. Gut 2004;53:1329\u201333.","journal-title":"Gut"},{"key":"9038_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","volume":"292","author":"H Ton","year":"2000","unstructured":"Ton H, Brandness Q, Holtlund J, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41\u201354.","journal-title":"Clin Chim Acta"},{"key":"9038_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gut.46.6.795","volume":"46","author":"O Kronborg","year":"2000","unstructured":"Kronborg O, Ustad M, Fuglerud P, et al. Fecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000;46:795\u2013800.","journal-title":"Gut"},{"key":"9038_CR4","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/j.1572-0241.2003.07630.x","volume":"98","author":"PJ Limburg","year":"2003","unstructured":"Limburg PJ, Devens ME, Harrington JJ, et al. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol 2003;98:2299\u2013305.","journal-title":"Am J Gastroenterol"},{"key":"9038_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15\u201322.","journal-title":"Gastroenterology"},{"key":"9038_CR6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","volume":"35","author":"F Costa","year":"2003","unstructured":"Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as a non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642\u20137.","journal-title":"Dig Liver Dis"},{"key":"9038_CR7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(00)03224-4","volume":"356","author":"MK Fagerhol","year":"2000","unstructured":"Fagerhol MK. Calprotectin. A faecal marker of organic gastrointestinal abnormality. Lancet 2000;356:1783\u20134.","journal-title":"Lancet"},{"key":"9038_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","volume":"32","author":"SA Riley","year":"1991","unstructured":"Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut 1991;32:174\u20138.","journal-title":"Gut"},{"key":"9038_CR9","first-page":"53","volume":"89","author":"R Modigliani","year":"1994","unstructured":"Modigliani R. Endoscopic management of inflammatory bowel disease. Am J Gastroenterol 1994;89:53\u201365.","journal-title":"Am J Gastroenterol"},{"key":"9038_CR10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF02237485","volume":"41","author":"J Kristinsson","year":"1998","unstructured":"Kristinsson J, Roseth A, Fagerhol MK, et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998;41:316\u201321.","journal-title":"Dis Colon Rectum"},{"key":"9038_CR11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/00365529609003120","volume":"31","author":"JA Gilbert","year":"1996","unstructured":"Gilbert JA, Ahlquist DA, Mahoney DW, et al. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. Scand J Gastroenterol 1996;31:1001\u20135.","journal-title":"Scand J Gastroenterol"},{"key":"9038_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/84.1.24","volume":"84","author":"IB Dale","year":"1985","unstructured":"Dale IB, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L-1) in human peripheral blood leukocytes. Am J Clin Pathol 1985;84:24\u201334.","journal-title":"Am J Clin Pathol"},{"key":"9038_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0609.1980.tb02754.x","volume":"24","author":"MK Fagerhol","year":"1980","unstructured":"Fagerhol MK, Dale I, Anderson I. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol 1980;24:393\u20138.","journal-title":"Scand J Haematol"},{"key":"9038_CR14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/00365529309098312","volume":"28","author":"AG Roseth","year":"1993","unstructured":"Roseth AG, Kristinsson J, Fagerhol MK, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28:1073\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"9038_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.49.3.402","volume":"49","author":"J Tibble","year":"2001","unstructured":"Tibble J, Sigthorsson G, Foster R, et al. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 2001;49:402\u20138.","journal-title":"Gut"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-200750120-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:51:45Z","timestamp":1786035105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003453-200750120-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1007\/s10350-007-9038-x","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}